By now, the economic burden of chronic disease in Canada has most likely surpassed $200 billion, according to Sarah Lussier Hoskyn, senior analyst, regulatory affairs and market access at Innovative Medicines Canada. “When you think about the total health-care budget in this country, we spent $250 billion in 2017 alone,” Lussier Hoskyn said during a session […]
Given the volume and depth of data available in benefits plans, as well as the complexity of problems to be solved, machine learning and broader artificial intelligence are unquestionably the future of plan and member health management. That said, there are some important challenges for plan sponsors to consider as they look at these new […]